Search results for "339"

showing 10 items of 33 documents

Hvordan er den fysiske formen blant norsk ungdom i alderen 13 til 15 år?

2007

Masteroppgave i idrettsvitenskap, Høgskolen i Agder Kristiansand Hensikt Hovedintensjonen med denne studien var å kartlegge den fysiske formen blant 13 til 15 åringer i Kristiansand kommune. I tillegg ble det sett nærmere på hvilken innvirkning pubertetsutviklingen har på den fysiske formen, hvilken innvirkning fysisk aktivitetsnivå har på fysisk form, samt hvor stor forekomsten av overvekt var for denne aldersgruppe. Metode Alle kommunale ungdomsskoler i Kristiansand kommune ble invitert og takket ja til å delta i prosjektet ”Ung i balanse”. Målgruppen var elever i 8. klasse høsten 2004. Disse elevene ble fulgt over en periode på to år, fra 8. til 10. klasse. Totalt var ca 1100 elever ford…

IDR506VDP::Samfunnsvitenskapelige idrettsfag:330::Andre idrettsfag:339VDP::helsefag:800::Idrettsmedisinske fag:850::Treningslære:851
researchProduct

Kehollisuuden merkitys suomalaisjuoksijoiden teknologian ei-käytölle

2022

Informaatiotutkimuksen päivätliikuntateknologiateknologiakritiikkimittausdigitalisaatio [http://www.yso.fi/onto/yso/p8692]General Medicineruumiillisuus [http://www.yso.fi/onto/yso/p4006]ruumiillisuusjuoksujuoksijatjuoksu [http://www.yso.fi/onto/yso/p9087]teknologia [http://www.yso.fi/onto/yso/p2339]puettava teknologialiikuntaharrastusinformaatio [http://www.yso.fi/onto/yso/p14428]kehollisuusInformaatiotutkimus
researchProduct

Role of dopamine and glutamate receptors in cocaine-induced social effects in isolated and grouped male OF1 mice.

2005

Cocaine administration in paired male mice decreases social contacts as well as increases avoidance and flee elements. As dopamine (DA) and glutamate seem to be involved in some of cocaine's effects, an attempt was made to assess whether a range of associated receptors influenced the social impacts of this drug of abuse. The NMDA antagonist memantine (10 and 40 mg/kg); the AMPA antagonist CNQX (1 and 20 mg/kg); the DA release inhibitor CGS 10746b (2 and 8 mg/kg): the DA D1 antagonist SCH 23390 (0.05 and 0.5 mg/kg); and the DA D2/D3 antagonist raclopride (0.03 and 0.3 mg/kg) were administered prior to 25 mg/kg of cocaine and behaviour was evaluated during an encounter between an experimental…

MaleClinical BiochemistryPharmacologyToxicologyBiochemistryReceptors DopamineBehavioral Neurosciencechemistry.chemical_compoundMiceCocainemedicineAnimalsBiological PsychiatryPharmacologyRacloprideSCH-23390Behavior AnimalMemantineDopamine antagonistAntagonistchemistryReceptors GlutamateSocial IsolationDopamine receptorCNQXNMDA receptorPsychologymedicine.drugPharmacology, biochemistry, and behavior
researchProduct

Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice.

1998

In this study, the antiaggressive effects of risperidone and SCH 23390 have been explored. Using the paradigm of isolation-induced aggression, 150 albino male mice of the OF1 strain were allocated to control and experimental groups which received three doses of risperidone (0.01, 0.05 and 0.1 mg/kg) or two doses of SCH 23390 (0.05 and 0.1 mg/kg). Only the highest doses of risperidone decreased threat and attack behaviours but all doses significantly impaired motor behaviour. SCH 23390 decreased attack with the two doses used and also produced significant increases in immobility. Although both antipsychotics are antiaggressive, this action seems to be more specific in the case of risperidone…

MaleMale micePharmacologyNeurotransmissionMotor Activitychemistry.chemical_compoundMiceSexual Behavior AnimalDopaminemedicineAnimalsPharmacology (medical)Biological PsychiatryPharmacologySCH-23390RisperidoneAggressionReceptors Dopamine D1BenzazepinesRisperidoneGroomingAggressionPsychiatry and Mental healthDopamine D2 Receptor AntagonistsNeurologychemistryIsolation induced aggressionSocial IsolationDepression ChemicalExploratory BehaviorDopamine AntagonistsFemaleNeurology (clinical)Serotoninmedicine.symptomPsychologymedicine.drugEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice.

2012

Background The rewarding effects of 3,4-methylenedioxy-metamphetamine (MDMA) have been demonstrated in conditioned place preference (CPP) procedures, but the involvement of the dopaminergic system in MDMA-induced CPP and reinstatement is poorly understood. Methodology/Principal Findings In this study, the effects of the DA D1 antagonist SCH 23390 (0.125 and 0.250 mg/kg), the DA D2 antagonist Haloperidol (0.1 and 0.2 mg/kg), the D2 antagonist Raclopride (0.3 and 0.6 mg/kg) and the dopamine release inhibitor CGS 10746B (3 and 10 mg/kg) on the acquisition, expression and reinstatement of a CPP induced by 10 mg/kg of MDMA were evaluated in adolescent mice. As expected, MDMA significantly increa…

MaleMouseThiazepinesDopaminelcsh:MedicineStriatumPharmacologychemistry.chemical_compoundBehavioral NeuroscienceHabitsMiceHaloperidolMedicinePsychologylcsh:ScienceRacloprideSCH-23390MultidisciplinaryAnimal BehaviorDopaminergicMDMAAnimal ModelsNeurotransmittersMental HealthMedicinepsychological phenomena and processesmedicine.drugResearch ArticleSerotoninN-Methyl-34-methylenedioxyamphetamineBlotting WesternModel OrganismsAnimalsBiologyBehaviorbusiness.industrylcsh:RAntagonistBenzazepinesAdjustment (Psychology)Conditioned place preferencechemistrynervous systemRacloprideDevelopmental PsychologyConditioning OperantDopamine AntagonistsHaloperidollcsh:QbusinessZoologyNeurosciencePLoS ONE
researchProduct

Effects of DA D1 and D2 antagonists on the sensitisation to the motor effects of morphine in mice

2002

Abstract Acute morphine administration produces hyperactivity in mice and repeated treatment induces an enhancement of this effect. In this experiment, we study the sensitisation to the hyperactivity induced by intermittent morphine administration (40 mg/kg) and the effects of dopamine (DA) antagonists on this phenomenon. Animals received three injections, separated by 48 h, and after each injection, their activity was registered between 30 and 60 min. In Experiment 1, animals were divided into two groups, which received saline and morphine (S–S–M) or only morphine (M–M–M). In Experiment 2, animals were divided into 12 groups. Half, which was designed to study the effects of DA antagonists …

MaleNarcoticsMotor ActivityPharmacologyMicechemistry.chemical_compoundDopamineAnimalsMedicineNeurotransmitterBiological PsychiatrySensitizationPharmacologyRacloprideSCH-23390Morphinebusiness.industryReceptors Dopamine D1AntagonistDopamine D2 Receptor Antagonistsmedicine.anatomical_structurechemistryToxicityMorphineDopamine Antagonistsbusinessmedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct

Lack of Specific Effects of Selective D1 and D2 Dopamine Antagonists vs. Risperidone on Morphine-Induced Hyperactivity

2000

Abstract RODRIGUEZ-ARIAS, M., I. BROSETA, M. A. AGUILAR AND J. MINARRO. Lack of specific effects of selective D 1 and D 2 dopamine antagonists on morphine-induced hyperactivity. PHARMACOL BIOCHEM BEHAV 66 (1) 189–197, 2000.—In the present study, three different dopamine antagonists were challenged in order to counteract hyperactivity induced by 50 mg/kg of morphine. A wide range of doses of morphine (50, 25, 12.5, 6.25, or 3.12 mg/kg) were evaluated on spontaneous locomotor activity. A significant increase was observed only with the two higher doses tested (25 and 50 mg/kg). No decrease was found with any of the doses used at any period of time. After analyzing doses of SCH 23390 (0.5, 0.1,…

MaleNarcoticsmedicine.medical_specialtyClinical BiochemistryMotor ActivityPharmacologyCatalepsyToxicologyBiochemistryMiceBehavioral Neurosciencechemistry.chemical_compoundDopamineInternal medicinemedicineAnimalsBiological PsychiatryPharmacologyRacloprideCatalepsySCH-23390RisperidoneMorphineChemistryReceptors Dopamine D1AntagonistDopamine antagonistBenzazepinesRisperidonemedicine.diseaseDopamine D2 Receptor AntagonistsEndocrinologyRacloprideMorphineDopamine Antagonistsmedicine.drugPharmacology Biochemistry and Behavior
researchProduct

Effects of SCH 23390, Raclopride, and Haloperidol on Morphine Withdrawal-Induced Aggression in Male Mice

1999

Abstract RODRIGUEZ-ARIAS, M., J. PINAZO, J. MINARRO AND L. STINUS. Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice. PHARMACOL BIOCHEM BEHAV 64(1) 123–130, 1999.—Dopamine seems to play a very important role in aggressive behavior observed in morphine withdrawal. The effect of SCH 23390 (0.5 mg/kg), raclopride (0.3 mg/kg), and haloperidol (0.1 mg/kg) on morphine withdrawal-induced aggression has been studied in this work. Mice were rendered dependent by a daily injection of morphine (2.5 mg/kg) for 14 days. Three different experiments were carried out with the objective to evaluate the antiaggressive effect of the dopamine antagonists o…

MaleNarcoticsmedicine.medical_specialtyNarcotic AntagonistsClinical BiochemistryPharmacologyToxicologyBiochemistryMiceBehavioral Neurosciencechemistry.chemical_compoundDopamineInternal medicineSalicylamidesmedicineHaloperidolAnimalsSocial BehaviorBiological PsychiatryPharmacologyRacloprideSCH-23390MorphineNaloxonebusiness.industryDopaminergicAntagonistDopamine antagonistBenzazepinesSubstance Withdrawal SyndromeAggressionEndocrinologychemistryRacloprideMorphineDopamine AntagonistsHaloperidolbusinessAntipsychotic Agentsmedicine.drugPharmacology Biochemistry and Behavior
researchProduct

Sex differences in the effects of neuroleptics on escape-avoidance behavior in mice: a review.

1999

Abstract The literature of the effects of dopamine antagonists on escape-avoidance, focusing on data obtained in our laboratory with male and female mice, is reviewed. The acute administration of haloperidol, raclopride, clozapine, and SCH 23390 impaired escape-avoidance behavior more in males than in females, and the subchronic administration of haloperidol had a similar effect. This appeared to be a reliable phenomenon, because it was observed in both kinds of administration, in two mouse strains, and with several drugs and doses. The observed results were dose dependent, although the dose–effect relationship was not the same in all drugs. The sex differences in escape avoidance did not s…

Malemedicine.medical_specialtyClinical BiochemistryToxicologyBiochemistryBehavioral Neurosciencechemistry.chemical_compoundMiceDopamineEscape ReactionInternal medicinemedicineHaloperidolAvoidance LearningAnimalsBiological PsychiatryClozapinePharmacologyRacloprideSCH-23390Sex CharacteristicsDopamine antagonistAntagonistEndocrinologychemistryDopamine receptorRacloprideHaloperidolFemalePsychologymedicine.drugAntipsychotic AgentsPharmacology, biochemistry, and behavior
researchProduct

Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice.

2001

The effects of dopamine (DA) antagonists with different selectivity for the DA receptors (SCH 23390, 0.5, 0.25, 0.125 mg/kg; haloperidol, 0.2, 0.1 mg/kg; raclopride, 1.2, 0.6, 0.3 mg/kg; risperidone, 0.4, 0.2, 0.1 mg/kg; U-99194A maleate, 40, 20 mg/kg; clozapine, 2.5, 1.25, 0.625 mg/kg) on the acquisition of place conditioning and morphine-induced conditioned place preference (CPP) were explored in male mice. Morphine (40 mg/kg) produced CPP while SCH 23390, haloperidol and clozapine (highest dose) and risperidone (lowest dose) produced conditioned place aversion (CPA). Raclopride and U-99194A maleate did not produce CPP or CPA. Morphine-induced CPP was reversed by the administration of SCH…

Malemedicine.medical_specialtyConditioning ClassicalPharmacologyChoice BehaviorReceptors DopamineBehavioral Neurosciencechemistry.chemical_compoundMiceDopamineInternal medicineOrientationpolycyclic compoundsmedicineHaloperidolAvoidance LearningAnimalsRacloprideSCH-23390MotivationDose-Response Relationship DrugMorphineChemistryAntagonistBrainConditioned place preferenceEndocrinologyDopamine receptorMorphineDopamine Antagonistsmedicine.drugBehavioural brain research
researchProduct